Your browser doesn't support javascript.
loading
Selective Laser Trabeculoplasty for the Treatment of Glaucoma: A Report by the American Academy of Ophthalmology.
Takusagawa, Hana L; Hoguet, Ambika; Sit, Arthur J; Rosdahl, Jullia A; Chopra, Vikas; Ou, Yvonne; Richter, Grace; Kim, Stephen J; WuDunn, Darrell.
Afiliación
  • Takusagawa HL; VA Eugene Healthcare Center, Eugene, Oregon and Casey Eye Institute, Oregon Health & Sciences University, Portland, Oregon. Electronic address: aambrus@aao.org.
  • Hoguet A; Ophthalmic Consultants of Boston, Boston, Massachusetts.
  • Sit AJ; Mayo Clinic, Department of Ophthalmology, Rochester, Minnesota.
  • Rosdahl JA; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
  • Chopra V; Doheny Eye Center UCLA, Pasadena, California.
  • Ou Y; Department of Ophthalmology, University of California San Francisco, San Francisco, California.
  • Richter G; Department of Ophthalmology, Southern California Permanente Medical Group, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California; USC Roski Eye Institute, Keck Medicine of University of Southern California, Los Angeles, California.
  • Kim SJ; Department of Ophthalmology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • WuDunn D; University of Florida College of Medicine-Jacksonville, Department of Ophthalmology, Jacksonville, Florida.
Ophthalmology ; 131(1): 37-47, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37702635
PURPOSE: To review the current published literature for high-quality studies on the use of selective laser trabeculoplasty (SLT) for the treatment of glaucoma. This is an update of the Ophthalmic Technology Assessment titled, "Laser Trabeculoplasty for Open-Angle Glaucoma," published in November 2011. METHODS: Literature searches in the PubMed database in March 2020, September 2021, August 2022, and March 2023 yielded 110 articles. The abstracts of these articles were examined to include those written since November 2011 and to exclude reviews and non-English articles. The panel reviewed 47 articles in full text, and 30 were found to fit the inclusion criteria. The panel methodologist assigned a level I rating to 19 studies and a level II rating to 11 studies. RESULTS: Data in the level I studies support the long-term effectiveness of SLT as primary treatment or as a supplemental therapy to glaucoma medications for patients with open-angle glaucoma. Several level I studies also found that SLT and argon laser trabeculoplasty (ALT) are equivalent in terms of safety and long-term efficacy. Level I evidence indicates that perioperative corticosteroid and nonsteroidal anti-inflammatory drug eye drops do not hinder the intraocular pressure (IOP)-lowering effect of SLT treatment. The impact of these eye drops on lowering IOP differed in various studies. No level I or II studies exist that determine the ideal power settings for SLT. CONCLUSIONS: Based on level I evidence, SLT is an effective long-term option for the treatment of open-angle glaucoma and is equivalent to ALT. It can be used as either a primary intervention, a replacement for medication, or an additional therapy with glaucoma medications. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oftalmología / Trabeculectomía / Glaucoma / Glaucoma de Ángulo Abierto Tipo de estudio: Health_technology_assessment Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Ophthalmology Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oftalmología / Trabeculectomía / Glaucoma / Glaucoma de Ángulo Abierto Tipo de estudio: Health_technology_assessment Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Ophthalmology Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos